rofecoxib has been researched along with Cerebral Infarction in 6 studies
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| " cerebral infarction, myocardial infarction and unstable angina pectoris, among rofecoxib and naproxen users in comparison to diclofenac users." | 3.76 | Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. ( Einarsdottir, R; Gudbjornsson, B; Halldorsson, M; Johannsson, M; Sigvaldason, H; Thorgeirsson, G; Thorsteinsson, SB; Zoega, H, 2010) |
| "To evaluate the site of action cerebral infarcted rats underwent single intracerebroventricular or intrathecal administration of FYO-750." | 1.36 | Improvement in neurogenic detrusor overactivity by peripheral C fiber's suppression with cyclooxygenase inhibitors. ( Akino, H; Aoki, Y; Nagase, K; Tanaka, I; Tanase, K; Yokoyama, O, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, I | 1 |
| Nagase, K | 1 |
| Tanase, K | 1 |
| Aoki, Y | 1 |
| Akino, H | 1 |
| Yokoyama, O | 1 |
| Gudbjornsson, B | 1 |
| Thorsteinsson, SB | 1 |
| Sigvaldason, H | 1 |
| Einarsdottir, R | 1 |
| Johannsson, M | 1 |
| Zoega, H | 1 |
| Halldorsson, M | 1 |
| Thorgeirsson, G | 1 |
| Frantz, S | 1 |
| Aizen, E | 1 |
| Kagan, G | 1 |
| Assy, B | 1 |
| Iobel, R | 1 |
| Bershadsky, Y | 1 |
| Gilhar, A | 1 |
| Palmer, K | 1 |
| Sawicki, PT | 1 |
| Bender, R | 1 |
| Selke, GW | 1 |
| Klauber, J | 1 |
| Gutschmidt, S | 1 |
1 trial available for rofecoxib and Cerebral Infarction
| Article | Year |
|---|---|
Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cerebral | 2005 |
5 other studies available for rofecoxib and Cerebral Infarction
| Article | Year |
|---|---|
Improvement in neurogenic detrusor overactivity by peripheral C fiber's suppression with cyclooxygenase inhibitors.
Topics: Animals; Cerebral Infarction; Cyclooxygenase Inhibitors; Female; Lactones; Nerve Fibers, Unmyelinate | 2010 |
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.
Topics: Angina, Unstable; Celecoxib; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Databases, Factual; D | 2010 |
How to avoid another 'Vioxx'.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cerebral Infarction; Clinical Trials as Topic; Cyclooxygena | 2005 |
The Vioxx fallout.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumat | 2005 |
[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004].
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Cerebral Infarction; Clinical Trials as Topic; Cross | 2006 |